We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Routine Blood Glucose Value Correlates with Diabetes Risk

By LabMedica International staff writers
Posted on 22 Mar 2015
Print article
Image: UniCel DxC 800 Synchron Clinical Systems (Photo courtesy of Beckman Coulter).
Image: UniCel DxC 800 Synchron Clinical Systems (Photo courtesy of Beckman Coulter).
Random glucose values obtained during routine blood tests are often overlooked, but could provide valuable insight into whether someone is at risk for having type 2 diabetes.

Random Blood Glucose (RBG) values in which the clinician is unaware of when the patient last ate account for the majority of glucose tests in clinical practice. Current guidelines do not call for using RBG values as a screening test for diabetes and do not consider higher levels an indicator of diabetes risk.

Scientists at the University of Texas Southwestern Medical Center (Dallas, TX, USA) analyzed data from 13,792 participants in the 2005-2010 National Health and Nutrition Examination Surveys, which tested participants for diabetes as part of the survey. The investigators examined the association between random blood glucose and a patient's diabetes status in patients without diagnosed diabetes. The study population consisted of non-pregnant adults, age18 and older.

Serum RBG measurements were determined using the Beckman Oxygen electrode, glucose oxidase method. Between 2007and 2012, one instrument change occurred as from 2008 the Beckman Unicel CxC800 Synchron (Beckman Coulter; Brea, CA, USA) was used. HbA1C assays were conducted using high-performance liquid chromatography (HPLC) methods mainly on the Tosoh HbA1C G7 (Tosoh Bioscience, Inc.; South San Francisco, CA, USA). Diabetes was defined as having an HbA1C ≥ 6.5% (48 mmol/mol) and prediabetes as having an HbA1C of 5.7–6.4% (39–46mmol/mol). Dysglycemia was defined as having an HbA1C ≥ 5.7% (39 mmol/mol).

The team found that those with even modest elevations in random blood glucose (RBG), between 100 to 119 mg/dL, were seven-times more likely to have diabetes, according to the study. As that number rose, so did the risk. Those with RBG values of 120 to 139 mg/dL were 30-times as likely to have undiagnosed diabetes. Individuals with values under 100 mg/dL served as a reference point and were not considered at risk.

Michael E. Bowen, MD, MPH, an assistant professor of Internal Medicine and lead author, said, “Our results provide compelling evidence that a single, elevated random blood glucose value is a strong risk factor for diabetes. After adjusting for traditional diabetes risk factors, we found that individuals with a single random glucose value greater than or equal to 100 mg/dL were 20-times more likely to have undiagnosed diabetes compared with those whose values were less than 100 mg/dL. We shouldn't ignore these values. If we do, we are missing an opportunity to identify patients at high risk for diabetes.” The study was published on February 4, 2015, in the Journal of Clinical Endocrinology and Metabolism.

Related Links:
University of Texas Southwestern Medical Center
Beckman Coulter 
Tosoh Bioscience 



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.